Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

12.73 +0.29 (+2.33%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 279,635
Open 12.46
Bid (Size) 12.53 (48)
Ask (Size) 15.50 (3)
Prev. Close 12.44
Today's Range 12.27 - 12.76
52wk Range 8.180 - 29.56
Shares Outstanding 47,147,781
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout
Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib. 
Via Benzinga
Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views
Via Benzinga

Performance

YTD
-34.8%
-34.8%
1 Month
+5.4%
+5.4%
3 Month
+21.1%
+21.1%
6 Month
-34.8%
-34.8%
1 Year
-34.4%
-34.4%

More News

Read More
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs
Via Benzinga
Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 Analysts
Via Benzinga
Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock
Via Benzinga
8 Analysts Have This To Say About Nurix Therapeutics
Via Benzinga
Decoding 9 Analyst Evaluations For Nurix Therapeutics
Via Benzinga
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts
Via Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Via Benzinga
Topics ETFs Stocks
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Unveiling 6 Analyst Insights On Nurix Therapeutics
Via Benzinga
Analyst Ratings For Nurix Therapeutics
Via Benzinga
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
Via Benzinga
Analyst Scoreboard: 12 Ratings For Nurix Therapeutics
Via Benzinga
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
Via Benzinga
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Nvidia’s Earnings Loom In The Summer Stock Snooze-Fest
Via Talk Markets
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Here Is What You Missed On Wall Street On Friday
Via Talk Markets
Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Via Benzinga
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Nurix Therapeutics, Inc. - Common stock publicly traded?
Yes, Nurix Therapeutics, Inc. - Common stock is publicly traded.
What exchange does Nurix Therapeutics, Inc. - Common stock trade on?
Nurix Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nurix Therapeutics, Inc. - Common stock?
The ticker symbol for Nurix Therapeutics, Inc. - Common stock is NRIX on the Nasdaq Stock Market
What is the current price of Nurix Therapeutics, Inc. - Common stock?
The current price of Nurix Therapeutics, Inc. - Common stock is 12.73
When was Nurix Therapeutics, Inc. - Common stock last traded?
The last trade of Nurix Therapeutics, Inc. - Common stock was at 07/03/25 01:00 PM ET
What is the market capitalization of Nurix Therapeutics, Inc. - Common stock?
The market capitalization of Nurix Therapeutics, Inc. - Common stock is 600.19M
How many shares of Nurix Therapeutics, Inc. - Common stock are outstanding?
Nurix Therapeutics, Inc. - Common stock has 600M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.